JAGX Stock Summary and Trading Ideas (Jaguar Health | NASDAQ:JAGX)

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

Jaguar Health trades on the NASDAQ stock market under the symbol JAGX.

As of April 25, 2024, JAGX stock price was flat at $0.17 with 17,023,397 million shares trading.

JAGX has a beta of -1.84, meaning it tends to be less sensitive to market movements. JAGX has a correlation of 0.02 to the broad based SPY ETF.

JAGX has a market cap of $48.83 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, JAGX stock traded as high as $513.00 and as low as $.05.

The top ETF exchange traded funds that JAGX belongs to (by Net Assets): VXF.

JAGX stock has underperformed the market in the last year with a return of -64.4%, while SPY returned +25.6%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in JAGX shares. However, JAGX has outperformed the market in the last 3 month and 2 week periods, returning +47.8% and +58.1%, while SPY returned +3.5% and -2.8%, respectively. This indicates JAGX has been having a stronger performance recently.

JAGX support price is $.15 and resistance is $.19 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that JAGX stock will trade within this expected range on the day.